|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Pharmacology and Toxicology, 2Institute of Molecular Medicine and Genetics, and 3Vascular Biology Center, Medical College of Georgia, Augusta, Georgia
Submitted 8 December 2006 ; accepted in final form 6 March 2007
Sex steroids exert profound and controversial effects on cardiovascular function. For example, estrogens have been reported to either ameliorate or exacerbate coronary heart disease. Although estrogen dilates coronary arteries from a variety of species, the molecular basis for this acute, nongenomic effect is unclear. Moreover, we know very little of how estrogen affects human coronary artery smooth muscle cells (HCASMC). The purpose of this study was to elucidate nongenomic estrogen signal transduction in HCASMC. We have used tissue (arterial tension studies), cellular (single-channel patch clamp, fluorescence), and molecular (protein expression) techniques to now identify novel targets of estrogen action in HCASMC: type I (neuronal) nitric oxide synthase (nNOS) and phosphatidylinositol 3-kinase (PI3-kinase)Akt. 17
-Estradiol (E2) increased NO-stimulated fluorescence in HCASMC, and cell-attached patch-clamp experiments revealed that stimulation of nNOS leads to increased activity of calcium-activated potassium (BKCa) channels in these cells. Furthermore, overexpression of nNOS protein in HCASMC greatly enhanced BKCa channel activity. Immunoblot studies demonstrated that E2 enhances Akt phosphorylation in HCASMC and that wortmannin, an inhibitor of PI3-kinase, attenuated E2-stimulated channel activity, NO production, Akt phosphorylation, and estrogen-stimulated coronary relaxation. These studies implicate the PI3-kinase/Akt signaling axis as an estrogen transduction component in vascular smooth muscle cells. We conclude, therefore, that estrogen opens BKCa channels in HCASMC by stimulating nNOS via a transduction sequence involving PI3-kinase and Akt. These findings now provide a molecular mechanism that can explain the clinical observation that estrogen enhances coronary blood flow in patients with diseased or damaged coronary arteries.
human coronary circulation; nitric oxide; heat shock protein 90
This article has been cited by other articles:
![]() |
A. M. Deschamps and E. Murphy Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1806 - H1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Han, H. Ma, R. Chintala, D. J. R. Fulton, S. A. Barman, and R. E. White Essential Role of the 90-Kilodalton Heat Shock Protein in Mediating Nongenomic Estrogen Signaling in Coronary Artery Smooth Muscle J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Burger, F.-L. Xiang, L. Hammoud, D. L. Jones, and Q. Feng Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 900 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. McCurnin, R. A. Pierce, B. C. Willis, L. Y. Chang, B. A. Yoder, I. S. Yuhanna, P. L. Ballard, R. I. Clyman, N. Waleh, W. Maniscalco, et al. Postnatal Estradiol Up-regulates Lung Nitric Oxide Synthases and Improves Lung Function in Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 492 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-A. Scott, A. Tremblay, M. Brochu, and J. St-Louis Vasorelaxant action of 17 -estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3713 - H3719. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |